Parkinson's Genetics: How What We're Learning Is Transforming Drug Development

This is an archived file of an event that took place on February 16, 2017. 

In this hour, our panelists discussed what we know about genetic mutations associated with Parkinson's and how growing understanding is helping us develop and test targeted therapies that may slow or stop progression.

Title: Parkinson's Genetics: How What We're Learning Is Transforming Drug Development

Duration: 1 hour

Continuing Medical Education Information for Health Care Professionals

MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

Date of Original Release: February 16, 2017
Date CME Credit No Longer Available: February 16, 2019

Learning Objectives
Posting before the live event

Target Audience
This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Oakstone Publishing, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.

Dave Iverson
No disclosures

Rachel Saunders-Pullman, MD, MPH
Associate Professor of Neurology
Mount Sinai Beth Israel Medical Center
Research-Grants: Gaucher Generations Program from Genzyme-Sanofi

Deborah Raymond, MS, CGC
Genetics Counselor
Mount Sinai Beth Israel Medical Center
No disclosures


Already Registered?

*Required Fields.

You must have Javascript and Cookies enabled to access this webcast. Click here for Help.

By registering you agree to receive email updates from
The Michael J. Fox Foundation. You can unsubscribe any time.